Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition

Abstract

Candesartan promotes a complementary antiproteinuric and a small antihypertensive effect after a treatment period of 8 weeks in patients with chronic glomerulonephritis when given in conjunction with an ACEI. Renal hemodynamics did not vary significantly.